Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07648901 · ClinicalTrials.gov registry record
Scale-Up Evaluation Trial of the Diabetes Prevention Program to Improve Obesity and Cardiometabolic Health After Traumatic Brain Injury
A clinical trial, sponsored by Baylor Research Institute.
- Not yet
- Registry status
- 70
- Enrollment target
NCT07648901: Clinical Trial study, sponsored by Baylor Research Institute.
NCT07648901 is a clinical trial that has not yet begun recruiting, run by Baylor Research Institute. The registered enrollment target is 70 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07648901 has not yet begun recruiting, sponsored by Baylor Research Institute.
- NOT YET RECRUITING
- Registry status
- 70 participants
- Enrollment target
Study Summary
The Investigators have proposed targeted efforts to address the feasibility, effectiveness, fidelity, and evaluation of the GLB-TBI Evidence Based Intervention (EBI) in a real world setting at a CDC-recognized site
Primary Outcome
Body weight will be measured at each session using an accessible scale.
Interventions
- BEHAVIORAL Group Lifestyle Balance for People with TBI (GLB-TBI)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2026-08-15 |
| Est. Completion | 2028-08-30 |
What is known before NCT07648901 opens enrollment
NCT07648901 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 70 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Group Lifestyle Balance for People with TBI (GLB-TBI) is the first listed.
NCT07648901 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07648901 about?
NCT07648901 is a clinical study titled "Scale-Up Evaluation Trial of the Diabetes Prevention Program to Improve Obesity and Cardiometabolic Health After Traumatic Brain Injury". The Investigators have proposed targeted efforts to address the feasibility, effectiveness, fidelity, and evaluation of the GLB-TBI Evidence Based Intervention (EBI) in a real world setting at a CDC-recognized site
What is the current status of trial NCT07648901?
This trial is currently not yet recruiting. The enrollment target is 70 participants. The study started on 2026-08-15. Estimated completion is 2028-08-30.
What interventions are being tested in trial NCT07648901?
The interventions under investigation include: Group Lifestyle Balance for People with TBI (GLB-TBI) (BEHAVIORAL).
Who is sponsoring clinical trial NCT07648901?
This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI